ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
10,600
Employees10,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
10,600
Employees10,600

RMD Key Statistics

Market cap
35.39B
Market cap35.39B
Price-Earnings ratio
25.17
Price-Earnings ratio25.17
Dividend yield
0.92%
Dividend yield0.92%
Average volume
972.14K
Average volume972.14K
High today
$247.78
High today$247.78
Low today
$241.66
Low today$241.66
Open price
$245.95
Open price$245.95
Volume
1.09M
Volume1.09M
52 Week high
$293.81
52 Week high$293.81
52 Week low
$199.92
52 Week low$199.92

Stock Snapshot

ResMed(RMD) stock is priced at $242.55, giving the company a market capitalization of 35.39B. It carries a P/E multiple of 25.17 and pays a dividend yield of 91.9%.

On 2025-12-19, ResMed(RMD) stock traded between a low of $241.66 and a high of $247.78. Shares are currently priced at $242.55, which is +0.4% above the low and -2.1% below the high.

The ResMed(RMD)'s current trading volume is 1.09M, compared to an average daily volume of 972.14K.

During the past year, ResMed(RMD) stock moved between $199.92 at its lowest and $293.81 at its peak.

During the past year, ResMed(RMD) stock moved between $199.92 at its lowest and $293.81 at its peak.

RMD News

TipRanks 19h
ResMed price target lowered to $260 from $270 at Stifel

Stifel analyst Jonathan Block lowered the firm’s price target on ResMed (RMD) to $260 from $270 and keeps a Hold rating on the shares. The stock’s recent pullba...

Nasdaq 4d
ResMed Shares Cross Above 200 DMA

In trading on Tuesday, shares of ResMed Inc. (Symbol: RMD) crossed above their 200 day moving average of $220.01, changing hands as high as $225.46 per share. R...

ResMed Shares Cross Above 200 DMA
Simply Wall St 5d
How FDA-Cleared AI Smart Comfort Personalization At ResMed Has Changed Its Investment Story

In December 2025, ResMed announced it had received U.S. FDA clearance for Smart Comfort, an AI-enabled feature that uses more than 100 million nights of de-iden...

How FDA-Cleared AI Smart Comfort Personalization At ResMed Has Changed Its Investment Story

Analyst ratings

72%

of 29 ratings
Buy
72.4%
Hold
24.1%
Sell
3.4%

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.